Paper8564359
BCG vaccination against tuberculosis: past disappointments and future hopes.
Roche PW and 2 others. Trends Microbiol, 1995. Cited by 65 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. BCG vaccination against tuberculosis: past disappointments and future hopes. Papers, record 8564359. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8564359
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BCG Vaccine | Major topic |
| Tuberculosis | Major topic |
| Animals | |
| Forecasting | |
| Humans |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,044,970 | Single-cell immune aging clocks reveal inter-individual heterogeneity during infection and vaccination. | Nat Aging | 2025 | https://conductscience.org/library/papers/40044970 | PubMed |
| 29,263,854 | Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice. | NPJ Vaccines | 2016 | https://conductscience.org/library/papers/29263854 | PubMed |
| 28,205,361 | Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine. | Cancer Med | 2017 | https://conductscience.org/library/papers/28205361 | PubMed |
| 25,152,895 | Dose of incorporated immunodominant antigen in recombinant BCG impacts modestly on Th1 immune response and protective efficiency against Mycobacterium tuberculosis in mice. | J Immunol Res | 2014 | https://conductscience.org/library/papers/25152895 | PubMed |
| 23,675,482 | Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice. | PLoS One | 2013 | https://conductscience.org/library/papers/23675482 | PubMed |
| 23,549,819 | Kinetics of IFN-gamma and TNF-alpha gene expression and their relationship with disease progression after infection with Mycobacterium tuberculosis in guinea pigs. | Yonsei Med J | 2013 | https://conductscience.org/library/papers/23549819 | PubMed |
| 22,861,360 | Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology. | Clin Exp Immunol | 2012 | https://conductscience.org/library/papers/22861360 | PubMed |
| 20,625,513 | Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. | PLoS One | 2010 | https://conductscience.org/library/papers/20625513 | PubMed |
| 20,353,397 | Recombinant Mycobacterium bovis BCG as an HIV vaccine vector. | Curr HIV Res | 2010 | https://conductscience.org/library/papers/20353397 | PubMed |
| 19,016,908 | Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route. | Immunology | 2009 | https://conductscience.org/library/papers/19016908 | PubMed |
| 18,724,774 | The guinea pig as a model of infectious diseases. | Comp Med | 2008 | https://conductscience.org/library/papers/18724774 | PubMed |
| 17,565,610 | Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-gamma activation. | Clin Exp Immunol | 2007 | https://conductscience.org/library/papers/17565610 | PubMed |
| 17,299,039 | Drying a tuberculosis vaccine without freezing. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17299039 | PubMed |
| 14,500,526 | Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus Calmette-Guérin vaccination. | Infect Immun | 2003 | https://conductscience.org/library/papers/14500526 | PubMed |
| 11,705,921 | Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells. | Infect Immun | 2001 | https://conductscience.org/library/papers/11705921 | PubMed |
| 10,768,993 | CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis. | Infect Immun | 2000 | https://conductscience.org/library/papers/10768993 | PubMed |
| 10,632,662 | Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guérin (BCG). | Clin Exp Immunol | 2000 | https://conductscience.org/library/papers/10632662 | PubMed |
| 10,024,540 | Generation of CD8(+) T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis. | Infect Immun | 1999 | https://conductscience.org/library/papers/10024540 | PubMed |
| 9,596,772 | Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. | Infect Immun | 1998 | https://conductscience.org/library/papers/9596772 | PubMed |
| 9,560,270 | Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9560270 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8564359
GET https://conductscience.org/api/papers/v1/8564359/cited_by?page=2